← Back to all trials
Completed
NCT04367506
Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness
Conditions: Tobacco Cessation
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 59
Sponsor: University of Maryland, Baltimore
Location: Melanie Bennett Baltimore Maryland
Summary
All patients with serious mental illness are abstinent while in the hospital for a psychiatric admission yet almost all return to smoking after discharge. The investigators propose to test a digital intervention adapted to the needs of SMI smokers and to being introduced in the inpatient psychiatric setting. Such an intervention could bridge the inpatient to outpatient gap in cessation services and will help people remain abstinent following hospital discharge.
Eligibility Criteria
Inclusion Criteria:
* Age 18 or greater
* Diagnosis of serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression)
* Current smoker \[prior to admission, smoked at least one cigarette or small cigar per day in the past month (unless restricted, e.g. due to ER/hospital visit) and smoked at least 100 cigarettes lifetime\]
* Interested in remaining quit after hospital discharge or quitting within the following 30 days
* Expected Internet use at least 3 times/week post-discharge and ownership of mobile device with text messaging plan post-discharge.
* Discharge destination within 1-hour of SPH given that Aim 3 involves biochemical verification (carbon monoxide testing).
* Reading competence as demonstrated by a score of \>= 37 on the Word Reading subtest of the Wide Range Achievement Test - 4th Edition (WRAT-4)168 to ensure the ability to engage in the intervention.
Exclusion Criteria:
* Intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness.
* Homeless prior to admission or anticipated to be homeless at discharge.
* Discharge to a residential setting where smoking is prohibited.
* Medical condition for which the use of nicotine replacement therapy (NRT) is contraindicated including pregnant, planning to become pregnant, or breastfeeding; within 4 weeks post myocardial infarction; severe arrhythmia, severe angina pectoris; peptic ulcer; severe renal failure; poorly controlled insulin-dependent diabetes; severely uncontrolled hypertension; peripheral vascular disease.
Source: ClinicalTrials.gov (NCT04367506). StuddyBuddy aggregates publicly available trial information.